Agenus Inc. , a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual Meeting that ...
Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...
Unemployment saw a slight decline from 5.3% to 5.2% in the Land of Lincoln in December, according to the U.S. Bureau of Labor ...
A joint meeting tomorrow between the Ministry of Education and the Onassis Foundation to finalize at least six of the 22 ...
Learn how to record and export professional video presentations in Microsoft PowerPoint. With voice narration, annotations, ...
At this time, I'd like to welcome everyone to the Biogen fourth-quarter and full-year 2024 earnings call and business update. [Operator instructions] Today's conference is being recorded. Thank you. I ...
Blueprint Medicines Corp (NASDAQ:BPMC) reported a challenging fourth quarter for 2024, missing analyst expectations for both earnings per share (EPS) and revenue. The company posted an EPS of -0.79, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback